Topic 384: CancerCostDetox: Detoxing Cancer Care Financial Toxicity
Brightoutcome Inc., Buffalo Grove IL
Investigators
Abstract
The prohibitive cost of cancer care has been widely described. Cancer treatment received by patients with insurance can still result in a considerable financial burden. Non-adherence is one of the best-studied outcomes resulting from higher care costs. Financial distress has also been linked to changes in treatment related decision making, including the decision against a treatment course because of cost. Addressing the costs of cancer care in the clinic is now described as a component of high-quality patient-centered care. Our overarching goal is to develop and evaluate CancerCostDetox, a cancer care decision support system with special focus on assessing patients? risk in financial hardship, calculating patients? out-of-pocket costs for different treatment options and facilitating the comparison of treatment options in terms of both effectiveness and cost, and providing tailored financial resources in alleviating the financial burden.
View original record on NIH RePORTER →